- Home
- SND vs TLSA Comparison
SND vs TLSA Comparison
Compare SND & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SND
- TLSA
- Stock Information
- Founded
- SND 2011
- TLSA 2013
- Country
- SND United States
- TLSA United Kingdom
- Employees
- SND N/A
- TLSA N/A
- Industry
- SND Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- TLSA Biotechnology: Pharmaceutical Preparations
- Sector
- SND Industrials
- TLSA Health Care
- Exchange
- SND Nasdaq
- TLSA Nasdaq
- Market Cap
- SND 87.9M
- TLSA 87.8M
- IPO Year
- SND 2016
- TLSA 2000
- Fundamental
- Price
- SND $2.32
- TLSA $1.57
- Analyst Decision
- SND Hold
- TLSA
- Analyst Count
- SND 2
- TLSA 0
- Target Price
- SND $2.63
- TLSA N/A
- AVG Volume (30 Days)
- SND 121.1K
- TLSA 1.4M
- Earning Date
- SND 03-03-2025
- TLSA 05-09-2025
- Dividend Yield
- SND 4.32%
- TLSA N/A
- EPS Growth
- SND N/A
- TLSA N/A
- EPS
- SND 0.08
- TLSA N/A
- Revenue
- SND $311,372,000.00
- TLSA N/A
- Revenue This Year
- SND N/A
- TLSA N/A
- Revenue Next Year
- SND N/A
- TLSA N/A
- P/E Ratio
- SND $30.03
- TLSA N/A
- Revenue Growth
- SND 5.20
- TLSA N/A
- 52 Week Low
- SND $1.73
- TLSA $0.41
- 52 Week High
- SND $2.80
- TLSA $1.91
- Technical
- Relative Strength Index (RSI)
- SND 57.30
- TLSA 67.29
- Support Level
- SND $1.88
- TLSA $1.25
- Resistance Level
- SND $2.20
- TLSA $1.59
- Average True Range (ATR)
- SND 0.11
- TLSA 0.25
- MACD
- SND 0.02
- TLSA 0.03
- Stochastic Oscillator
- SND 96.67
- TLSA 68.52
About SND Smart Sand Inc.
Smart Sand Inc. is a fully integrated frac sand company providing mine-to-well site proppant supply and logistics. It produces Northern White frac sand for enhanced hydrocarbon recovery in oil and gas wells. The company offers products like Smart System, SmartBelt, SmartDepot Silo, and SmartPath Loader. It is expanding into industrial markets, including glass, ceramics, and renewable energy, while its main revenue comes from sand sales and logistics.
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.